These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3182447

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Studies on ciprofloxacin therapy of experimental Legionnaires' disease.
    Fitzgeorge RB, Gibson DH, Jepras R, Baskerville A.
    J Infect; 1985 May; 10(3):194-203. PubMed ID: 3161954
    [Abstract] [Full Text] [Related]

  • 23. The course of Legionella pneumonia in guinea pigs after inhalation of various quantities of L. pneumophila.
    Twisk-Meijssen MJ, Meenhorst PL, van Cronenburg BJ, Mulder JD, Scheffer E, van Furth R.
    Immunobiology; 1987 Dec; 176(1-2):108-24. PubMed ID: 3447980
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. New beta-lactamase-resistant cephem treatment of guinea pigs infected with Legionella pneumophila.
    Toro J, Sawatari K, Kanda T, Saito A, Hara K.
    Microbiol Immunol; 1983 Dec; 27(8):649-54. PubMed ID: 6316115
    [Abstract] [Full Text] [Related]

  • 26. A self-limited febrile illness produced in guinea pigs associated with oral administration of Legionella pneumophila.
    Katz SM, Hammel JM, Matus JP, Poropatich R, Katz J.
    Gastroenterology; 1988 Dec; 95(6):1575-81. PubMed ID: 3181681
    [Abstract] [Full Text] [Related]

  • 27. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F, Arakaki N, Tateyama M, Koide M, Shinzato T, Kawakami K, Saito A.
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [Abstract] [Full Text] [Related]

  • 28. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
    Kohno S, Koga H, Yamaguchi K, Masaki M, Inoue Y, Dotsu Y, Masuyama Y, Hayashi T, Hirota M, Saito A.
    J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of NY-198 against experimental Legionnaires disease.
    Kohno S, Yamaguchi K, Dohtsu Y, Koga H, Hayashi T, Hirota M, Saito A, Hara K.
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1427-9. PubMed ID: 3196003
    [Abstract] [Full Text] [Related]

  • 30. An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease.
    Blander SJ, Szeto L, Shuman HA, Horwitz MA.
    J Clin Invest; 1990 Sep; 86(3):817-24. PubMed ID: 2203824
    [Abstract] [Full Text] [Related]

  • 31. Increased plasma adenosine deaminase activity in the early phase of Legionella pneumophila infection in guinea pigs.
    Nikaido Y, Nagata N, Kido M, Yoshida S.
    FEMS Immunol Med Microbiol; 1996 May; 14(1):39-43. PubMed ID: 8804974
    [Abstract] [Full Text] [Related]

  • 32. In vitro and in vivo efficacy of fusafungine on Legionella pneumophila.
    Pocidalo JJ, Assous M.
    Rhinol Suppl; 1988 May; 5():45-53. PubMed ID: 3244983
    [No Abstract] [Full Text] [Related]

  • 33. Non-specific protection against pulmonary Legionella pneumophila infection in guinea-pigs immunized and challenged with mycobacteria.
    Gibson DH, Baskerville A, Ashworth LA, Fitzgeorge RB.
    Br J Exp Pathol; 1985 Jun; 66(3):333-44. PubMed ID: 3924087
    [Abstract] [Full Text] [Related]

  • 34. Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs.
    Edelstein PH, Calarco K, Yasui VK.
    Am Rev Respir Dis; 1984 Nov; 130(5):849-56. PubMed ID: 6333840
    [Abstract] [Full Text] [Related]

  • 35. A live avirulent mutant Legionella pneumophila vaccine induces protective immunity against lethal aerosol challenge.
    Blander SJ, Breiman RF, Horwitz MA.
    J Clin Invest; 1989 Mar; 83(3):810-5. PubMed ID: 2646318
    [Abstract] [Full Text] [Related]

  • 36. Bactericidal effects of co-amoxiclav (amoxycillin clavulanic acid) against a Legionella pneumophila pneumonia in the immunocompromised weanling rat.
    Smith GM, Abbott KH, Sutherland R.
    J Antimicrob Chemother; 1992 Oct; 30(4):525-34. PubMed ID: 1490922
    [Abstract] [Full Text] [Related]

  • 37. Comparison of ciprofloxacin and rifampicin in experimental Legionella pneumophila pneumonia.
    Havlichek D, Pohlod D, Saravolatz L.
    J Antimicrob Chemother; 1987 Dec; 20(6):875-81. PubMed ID: 3440771
    [Abstract] [Full Text] [Related]

  • 38. [Treatment of severe respiratory infection. Legionella pneumonia].
    Saito A.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):281-5. PubMed ID: 2615084
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of imipenem in experimental Legionnaires' disease.
    Fitzgeorge RB, Gibson DH, Jepras RI, Baskerville A.
    Lancet; 1985 Mar 16; 1(8429):633-4. PubMed ID: 2857963
    [No Abstract] [Full Text] [Related]

  • 40. Review of azithromycin activity against Legionella spp.
    Edelstein PH.
    Pathol Biol (Paris); 1995 Jun 16; 43(6):569-72. PubMed ID: 8539085
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.